With rich experience in digital implementation for overseas factories, we understand regional industrial regulations and diverse project management practices. Our full project lifecycle adheres to international compliance standards including GMP and GAMP5. Our overseas service network covers North America (US, Canada), Europe (Germany, Belgium), Asia (South Korea, Singapore, Indonesia) and Hong Kong, China, to guarantee efficient project rollout, reliable delivery and continuous maintenance.

We focus on digitalization and automation for pharmaceutical and batch process industries. We have served renowned domestic and global enterprises including AstraZeneca, Merck, Novartis, Pfizer, Amoytop Biotech, Gan & Lee Pharmaceutical, WuXi Biologics, Byhealth, Feihe Dairy, Mengniu Dairy, Fuchs Lubricants, Sika, SOUDAL and more.

We have accumulated numerous lighthouse benchmark projects, and help enterprises achieve their smart manufacturing goals with mature industry solutions.

Covers 90% of business processes in the process industry, enables business differentiation through modular configuration

Fully separated front-end and back-end development architecture, supporting the reuse and expansion of existing functionalities

Backend-encapsulated general interfaces, direct invocation of these interfaces enables common business operations without requiring frontend development, frontend-general components allow page display through direct parameter assembly and transmission

It is required to solve the problem of a large number of informatization systems and the contradiction between demand and supply. Currently, frequent market changes lead to increased plan modifications, resulting in inefficient resource utilization and inflexible deployment. The plant faces challenges such as numerous products, small batches, and difficulties in agile switching. Low collaboration efficiency and ineffective information flow during production can even trigger operational errors. This scenario not only incurs substantial resource costs but also suffers from poor traceability due to information silos.

It addresses and optimizes the requirements for ensuring global unified GMP compliance and the standardization of global unified process flows. All operations in the production process are traceable, recordable, and controllable. It strengthens compliance with the requirements of the "Two Laws" and "Two Regulations", thereby enhancing the consistency of drug quality. The process safety, audit trails, and electronic record standards in production and testing are relatively high. By leveraging the improvement of intelligent levels, it reduces manual intervention and enhances quality stability.